Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennie L Conroy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
ACS Chemical Neuroscience|February 10, 2015
Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptorJennie L Conroy, R Benjamin Free, David R Sibley
Brain Research|January 10, 2013
CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociceptionJennie L Conroy, Julia W Nalwalk, James G Phillips, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
PNA-Based Multivalent Scaffolds Activate the Dopamine D2 ReceptorAndrew V Dix, Jennie L Conroy, Kara M George Rosenker, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2020
Development of pyrimidone D1 dopamine receptor positive allosteric modulatorsKathryn D Luderman, Prashi Jain, R Benjamin Free, et al.
The International Journal of Neuropsychopharmacology|July 26, 2012
Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptorsJack Bergman, Rebecca A Roof, Cheryse A Furman, et al.
Psychopharmacology|September 19, 2014
(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signalingJulie A Meade, R Benjamin Free, Nicole R Miller, et al.
Journal of Medicinal Chemistry|March 27, 2014
Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonistsJingbo Xiao, R Benjamin Free, Elena Barnaeva, et al.
Pain|February 15, 2011
Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesicLindsay B Hough, Julia W Nalwalk, Jun Yang, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Nature Neuroscience|February 9, 2010
Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signalingJennie L Conroy, Cheng Fang, Jun Gu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
ACS Chemical Neuroscience|February 10, 2015
Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptorJennie L Conroy, R Benjamin Free, David R Sibley
Brain Research|January 10, 2013
CC12, a P450/epoxygenase inhibitor, acts in the rat rostral, ventromedial medulla to attenuate morphine antinociceptionJennie L Conroy, Julia W Nalwalk, James G Phillips, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
PNA-Based Multivalent Scaffolds Activate the Dopamine D2 ReceptorAndrew V Dix, Jennie L Conroy, Kara M George Rosenker, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2020
Development of pyrimidone D1 dopamine receptor positive allosteric modulatorsKathryn D Luderman, Prashi Jain, R Benjamin Free, et al.
The International Journal of Neuropsychopharmacology|July 26, 2012
Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptorsJack Bergman, Rebecca A Roof, Cheryse A Furman, et al.
Psychopharmacology|September 19, 2014
(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signalingJulie A Meade, R Benjamin Free, Nicole R Miller, et al.
Journal of Medicinal Chemistry|March 27, 2014
Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonistsJingbo Xiao, R Benjamin Free, Elena Barnaeva, et al.
Pain|February 15, 2011
Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesicLindsay B Hough, Julia W Nalwalk, Jun Yang, et al.
Molecular Pharmacology|August 3, 2018
Identification of Positive Allosteric Modulators of the D<sub>1</sub> Dopamine Receptor That Act at Diverse Binding SitesKathryn D Luderman, Jennie L Conroy, R Benjamin Free, et al.
Nature Neuroscience|February 9, 2010
Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signalingJennie L Conroy, Cheng Fang, Jun Gu, et al.
Pageof 2